Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 13/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 12/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | POLA1 | P09884 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13899941 | 0.71 | ESR1 (0.54) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL26135919 | 0.67 | MEN1 (0.42) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL3849270 | 0.66 | ESR2 (0.46) | ESR1ESR2 | |
| SCHEMBL3431277 | 0.66 | ESR2 (0.52) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL4236973 | 0.66 | ALDH1A1 (0.49) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL218608 | 0.65 | ALDH1A1 (0.44) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL29646235 | 0.65 | ALDH1A1 (0.44) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL29646238 | 0.65 | ALDH1A1 (0.44) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL14158763 | 0.64 | ESR2 (0.41) | OPRM1OPRK1OPRD1ESR1ESR2 | |
| SCHEMBL13899939 | 0.63 | ESR2 (0.69) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003502277-A | — | — | 2003-01-21 | — | — | JP | claimed |
| EP-1140815-A1 | NOVEL THIO-AMINOTETRALIN COMPOUNDS USEFUL IN PAIN MANAGEMENT | AstraZeneca AB (SE) | 2001-10-10 | — | — | EP | claimed |
| WO-2000037438-A1 | NOVEL THIO-AMINOTETRALIN COMPOUNDS USEFUL IN PAIN MANAGEMENT | ASTRAZENECA AB (SE) | 2000-06-29 | — | — | WO | claimed |
| EP-1140815-A1 | NOVEL THIO-AMINOTETRALIN COMPOUNDS USEFUL IN PAIN MANAGEMENT | AstraZeneca AB (SE) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037438-A1 | NOVEL THIO-AMINOTETRALIN COMPOUNDS USEFUL IN PAIN MANAGEMENT | ASTRAZENECA AB (SE) | 2000-06-29 | — | — | WO | disclosed |